Skip to search formSkip to main contentSkip to account menu

acexamic acid

Known as: N-acetylamino-6-hexanoic acid, 6-(acetylamino)hexanoic acid, Hexanoic acid, 6-(acetylamino)- 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (2)

AminocaproatesAnti-Inflammatory Agents, Non-Steroidal

Narrower (4)

NAS-501Plastenansodium acexamatezinc acexamate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Allergic contact dermatitis to acexamic acid
A 66-year-old woman, with stasis dermatitis, hypertension, and hypercholesterolemia, but no previous story of atopy, has been… 
2004
2004
The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide
SummaryThe acute toxicities of the cellular differentiating agent hexamethylene bisacetamide (HMBA) in humans and animals include… 
1996
1996
Zinc Uptake in Five Sectors of the Rat Gastrointestinal Tract: Kinetic Study in the Whole Colon
AbstractPurpose. The uptake of zinc as acexamic acid salt in the rat gastrointestinal tract, using an in situ static technique… 
1993
1993
Alkylamides as inducers of human leukemia cell differentiation: a quantitative structure-activity relationship study using comparative molecular field analysis.
Computer assisted quantitative structure-activity studies using comparative molecular field analysis (CoMFA) were performed on a… 
1991
1991
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.
A Phase I clinical trial and pharmacological study of nasogastrically administered hexamethylene bisacetamide, a polar-planar… 
1990
1990
Effects of the monoamine oxidase inhibitor, tranylcypromine, on induction of HL60 cell differentiation by hexamethylene bisacetamide and N-acetyl-1,6-diaminohexane.
Hexamethylene bisacetamide (HMBA) is converted by successive deacetylation and oxidation reactions to four major metabolites; in… 
1988
1988
Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
We studied the ability of five metabolites of hexamethylene bisacetamide (HMBA), which we had previously identified in patient… 
1988
1988
Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.
We investigated whether leukemic cell lines could convert hexamethylene bisacetamide (HMBA) to any of the metabolites previously… 
1986
1986
Identification of metabolites of the cell-differentiating agent hexamethylene bisacetamide in humans.
Hexamethylene bisacetamide, a compound which in vitro induces differentiation in a wide variety of human and animal cancer cell… 
1979
1979
[So-called refractory hypoxemia: treatment with acexamic acid].
Acexamic acid is currently used to avoid pulmonary fibrosis in patients treated with bleomycim. It seems to be equally effective… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)